The role of PACAP in central cardiorespiratory regulation

Respiratory Physiology and Neurobiology

Volumn 174, Issue 1-2, 2010, Pages 65-75

  Farnham, Melissa M J ^a   Pilowsky, Paul M ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

Central cardiorespiratory regulation; Glucagon; Hippocampal function; Sympathetic nerve activity

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE;

CARDIOVASCULAR FUNCTION; HUMAN; MEDULLA OBLONGATA; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATION CONTROL; REVIEW; SPINAL CORD; SUDDEN INFANT DEATH SYNDROME;

EID: 78049379790     PISSN: 15699048     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resp.2010.05.004     Document Type: Review

References (171)

1. Abad C., Niewiadomski P., Loh D., Waschek J. Neurotransmitter and immunomodulatory actions of VIP and PACAP: lessons from knockout mice. Int. J. Pept. Res. Ther. 2006, 12:297-310.
2. Abbott S.B.G., Burke P.G.R., Pilowsky P.M. Galanin microinjection into the PreBötzinger or the Bötzinger Complex terminates central inspiratory activity and reduces responses to hypoxia and hypercapnia in rat. Resp. Physiol. Neurobiol. 2009, 167:299-306.
3. Adams B.A., Gray S.L., Isaac E.R., Bianco A.C., Vidal-Puig A.J., Sherwood N.M. Feeding and metabolism in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Endocrinology 2008, 149:1571-1580.
4. Ajpru S., McArthur A.J., Piggins H.D., Sugden D. Identification of PAC1 receptor isoform mRNAs by real-time PCR in rat suprachiasmatic nucleus. Mol. Brain Res. 2002, 105:29-37.
5. Akesson L., Ahren B., Edgren G., Degerman E. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Endocrinology 2005, 146:744-750.
6. Anderson S., Kusters D., Clarke I., Pow D., Curlewis J. Expression of pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1R) in the ewe hypothalamus: distribution and colocalization with tyrosine hydroxylase-immunoreactive neurones. J. Neuroendocrinol. 2005, 17:298-305.
7. Arimura A. Receptors for pituitary adenylate cyclase-activating polypeptide Comparison with vasoactive intestinal peptide receptors. Trends Endocrinol. Metab. 1992, 3:288-294.
8. Arimura A. Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn. J. Physiol. 1998, 48:301-331.
9. Arimura A., Shioda S. Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction. Front. Neuroendocrinol. 1995, 16:53-88.
10. Arimura A., Somogyvari-Vigh A., Miyata A., Mizuno K., Coy D.H., Kitada C. Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. Endocrinology 1991, 129:2787-2789.
11. Asnicar M.A., Koster A., Heiman M.L., Tinsley F., Smith D.P., Galbreath E., Fox N., Ma Y.L., Blum W.F., Hsiung H.M. Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate. Endocrinology 2002, 143:3994-4006.
12. Babinski K., Bodart V., Roy M., Lean A.D., Ong H. Pituitary adenylate-cyclase activating polypeptide (PACAP) evokes long-lasting secretion and de novo biosynthesis of bovine adrenal medullary neuropeptides. Neuropeptides 1996, 30:572-582.
13. Baker-Herman T.L., Fuller D.D., Bavis R.W., Zabka A.G., Golder F.J., Doperalski N.J., Johnson R.A., Watters J.J., Mitchell G.S. BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nat. Neurosci. 2004, 7:48-55.
14. Banks W., Kastin A., Komaki G., Arimura A. Passage of pituitary adenylate cyclase activating polypeptide 1-27 and pituitary adenylate cyclase activating polypeptide 1-38 across the blood-brain barrier. J. Pharmacol. Exp. Ther. 1993, 267:690-696.
15. Banks W.A., Kastin A.J., Arimura A. Effect of spinal cord injury on the permeability of the blood-brain and blood-spinal cord barriers to the neurotropin PACAP. Exp. Neurol. 1998, 151:116-123.
16. Beaudet M.M., Braas K.M., May V. Pituitary adenylate cyclase activating polypeptide (PACAP) expression in sympathetic preganglionic projection neurons to the superior cervical ganglion. J. Neurobiol. 1998, 36:325-336.
17. Bobrovskaya L., Gelain D.P., Gilligan C., Dickson P.W., Dunkley P.R. PACAP stimulates the sustained phosphorylation of tyrosine hydroxylase at serine 40. Cell Signal. 2007, 19:1141-1149.
18. Borba J.C., Henze I.P., Silveira M.S., Kubrusly R.C.C. Gardino PF, de Mello MCF, Hokoc JN, de Mello FG, Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development. Dev. Brain Res. 2005, 156:193-201.
19. Bourgault S., Vaudry D., Guilhaudis L., Raoult É., Couvineau A., Laburthe M., Ségalas-Milazzo I., Vaudry H., Fournier A. Biological and structural analysis of truncated analogs of PACAP27. J. Mol. Neurosci. 2008, 36:260-269.
20. Braas K.M., May V., Harakall S.A., Hardwick J.C., Parsons R.L. Pituitary adenylate cyclase-activating polypeptide expression and modulation of neuronal excitability in guinea pig cardiac ganglia. J. Neurosci. 1998, 18:9766-9779.
21. Brenneman D.E. Neuroprotection: a comparative view of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Peptides 2007, 28:1720-1726.
22. Burke P.G.R., Abbott S.B.G., McMullan S., Goodchild A.K., Pilowsky P.M. Somatostatin selectively ablates post-inspiratory activity after injection into the Bötzinger complex. Neuroscience 2010, 10.1016/j.neuroscience.2010.01.065.
23. Buscail L., Gourlet P., Cauvin A., De Neef P., Gossen D., Arimura A., Miyata A., Coy D.H., Robberecht P., Christophe J. Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J. FEBS Lett. 1990, 262:77-81.
24. Cagampang F.R., Piggins H.D., Sheward W.J., Harmar A.J., Coen C.W. Circadian changes in PACAP type 1 (PAC1) receptor mRNA in the rat suprachiasmatic and supraoptic nuclei. Brain Res. 1998, 813:218-222.
25. Cagampang F.R., Sheward W.J., Harmar A.J., Piggins H.D., Coen C.W. Circadian changes in the expression of vasoactive intestinal peptide 2 receptor mRNA in the rat suprachiasmatic nuclei. Mol. Brain Res. 1998, 54:108-112.
26. Card J.P., Sved J.C., Craig B., Raizada M., Vazquez J., Sved A.F. Efferent projections of rat rostroventrolateral medulla C1 catecholamine neurons: Implications for the central control of cardiovascular regulation. J. Comp. Neurol. 2006, 499:840-859.
27. Cardell L.O., Uddman R., Luts A., Sundler F. Pituitary adenylate cyclase activating peptide (PACAP) in guinea-pig lung: distribution and dilatory effects. Regul. Peptides 1991, 36:379-390.
28. Cauvin A., Buscail L., Gourlet P., De Neef P., Gossen D., Arimura A., Miyata A., Coy D.H., Robberecht P., Christophe J. The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK. Peptides 1990, 11:773-777.
29. Champion H.C., Santiago J.A., Garrison E.A., Cheng D.Y., Coy D.H., Murphy W.A., Ascuitto R.J., Ross-Ascuitto N.T., McNamara D.B., Kadowitz P.J. Analysis of cardiovascular responses to PACAP-27, PACAP-38, and vasoactive intestinal polypeptide. Ann NY Acad Sci 1996, New York Acad Sciences, New York, pp. 429-442.
30. Chen D., Buchanan G.F., Ding J.M., Hannibal J., Gillette M.U. Pituitary adenylyl cyclase-activating peptide: a pivotal modulator of glutamatergic regulation of the suprachiasmatic circadian clock. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:13468-13473.
31. Chen Y., Samal B., Hamelink C.R., Xiang C.C., Chen Y., Chen M., Vaudry D., Brownstein M.J., Hallenbeck J.M., Eiden L.E. Neuroprotection by endogenous and exogenous PACAP following stroke. Regul. Peptides 2006, 137:4-19.
32. Chiba T., Tanaka K., Tatsuoka H., Dun S.L., Dun N.J. The synaptic structure of PACAP immunoreactive axons in the intermediolateral nucleus of the rat. Neurosci. Lett. 1996, 214:65-68.
33. Choi H.J., Park S.Y., Hwang O. Differential involvement of PKA and PKC in regulation of catecholamine enzyme genes by PACAP. Peptides 1999, 20:817-822.
34. Colwell C.S., Menaker M. Regulation of circadian rhytms by excitatory amino acids. Excitatory Amino Acids: Their Role in Neuroendocrine Function 1996, pp. 223-252.
35. Colwell C.S., Michel S., Itri J., Rodriguez W., Tam J., Lelievre V., Hu Z., Waschek J.A. Selective deficits in the circadian light response in mice lacking PACAP. Am. J. Physiol.: Reg. I 2004, 287:R1194-1201.
36. Corbitt J., Vivekananda J., Wang S.S., Strong R. Transcriptional and posttranscriptional control of tyrosine hydroxylase gene expression during persistent stimulation of pituitary adenylate cyclase-activating polypeptide receptors on PC12 cells: regulation by protein kinase A-dependent and protein kinase A-independent pathways. J. Neurochem. 1998, 71:478-486.
37. Corbitt J., Hagerty T., Fernandez E., Morgan W.W., Strong R. Transcriptional and post-transcriptional regulation of Tyrosine Hydroxylase messenger RNA in PC12 cells during persistent stimulation by VIP and PACAP38: differential regulation by protein kinase A and protein kinase C-dependent pathways. Neuropeptides 2002, 36:34-45.
38. Cummings K.J., Willie C., Wilson R.J.A. Pituitary adenylate cyclase-activating polypeptide maintains neonatal breathing but not metabolism during mild reductions in ambient temperature. Am. J. Physiol. 2008, 294:R956-965.
39. Cummings K.J., Pendlebury J.D., Sherwood N.M., Wilson R.J.A. Sudden neonatal death in PACAP-deficient mice is associated with reduced respiratory chemoresponse and susceptibility to apnoea. J. Physiol. 2004, 555:15-26.
40. Dalsgaard T., Hannibal J., Fahrenkrug J., Larsen C.R., Ottesen B. VIP and PACAP display different vasodilatory effects in rabbit coronary and cerebral arteries. Regul. Peptides 2003, 110:179-188.
41. Das M., Vihlen C.S., Legradi G. Hypothalamic and brainstem sources of pituitary adenylate cyclase-activating polypeptide nerve fibers innervating the hypothalamic paraventricular nucleus in the rat. J. Comp. Neurol. 2007, 500:761-776.
42. Davis-Taber R., Baker S., Lehto S.G., Zhong C., Surowy C.S., Faltynek C.R., Scott V.E., Honore P. Central pituitary adenylate cyclase 1 receptors modulate nociceptive behaviors in both inflammatory and neuropathic pain states. J. Pain 2008, 9:449-456.
43. Dejda A., Sokolowska P., Nowak J.Z. Neuroprotective potential of three neuropeptides PACAP, VIP and PHI. Pharmacol. Rep. 2005, 57:307-320.
44. Dickson L., Finlayson K. VPAC and PAC receptors: from ligands to function. Pharmacol. Ther. 2009, 121:294-316.
45. Doberer D., Gschwandtner M., Mosgoeller W., Bieglmayer C., Heinzl H., Petkov V. Pulmonary and systemic effects of inhaled PACAP38 in healthy male subjects. Eur. J. Clin. Invest. 2007, 37(8):665-672.
46. Dong W., Seidel B., Marcinkiewicz M., Chretien M., Seidah N.G., Day R. Cellular localization of the prohormone convertases in the hypothalamic paraventricular and supraoptic nuclei: selective regulation of PC1 in corticotrophin-releasing hormone parvocellular neurons mediated by glucocorticoids. J. Neurosci. 1997, 17:563-575.
47. Dun E.C., Huang R.L., Dun S.L., Dun N.J. Pituitary adenylate cyclase activating polypeptide-immunoreactivity in human spinal cord and dorsal root ganglia. Brain Res. 1996, 721:233-237.
48. Dun N.J., Miyazaki T., Tang H., Dun E.C. Pituitary adenylate cyclase activating polypeptide immunoreactivity in the rat spinal cord and medulla: implication of sensory and autonomic functions. Neuroscience 1996, 73:677.
49. Durr K., Norsted E., Gomuc B., Suarez E., Hannibal J., Meister B. Presence of pituitary adenylate cyclase-activating polypeptide (PACAP) defines a subpopulation of hypothalamic POMC neurons. Brain Res. 2007, 1186:203-211.
50. El Fahime E., Lutz-Bucher B., Felix J.M., Koch B. Pituitary adenylate cyclase-activating polypeptide induces expression of corticosteroid-binding globulin in cultured fetal hepatocytes: synergy with tri-iodothyronine. Biochem. J. 1996, 315(Pt 2):643-649.
51. Erickson C.C., Champion H.C., Santiago J.A., Garisson E.A., Fry R.C., Simoneaux M.L., Marrone J.R., Kadowitz P.J. Comparison of responses to PACAP-27, PACAP-38, and VIP: effect of PACAP (6-27) in the hindquarters vascular bed of the cat. FASEB J. 1996, 10:4016-14016.
52. Fahrenkrug J., Hannibal J., Tams J., Georg B. Immunohistochemical localization of the VIP1 receptor (VPAC(1)R) in rat cerebral blood vessels: relation to PACAP and VIP containing nerves. J. Cerebr. Blood F. Met. 2000, 20:1205-1214.
53. Farnham M.M.J., Li Q., Goodchild A.K., Pilowsky P.M. PACAP is expressed in sympathoexcitatory bulbospinal C1 neurons of the brain stem and increases sympathetic nerve activity in vivo. Am. J. Physiol. 2008, 294:R1304-1311.
54. Filipsson K., Tornoe K., Holst J., Ahren B. Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans. J. Clin. Endocrinol. Metab. 1997, 82:3093-3098.
55. Fizanne L., Sigaudo-Roussel D., Saumet J.L., Fromy B. Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents. J. Physiol. (Lond.) 2004, 554:519-528.
56. Gardiner S.M., Rakhit T., Kemp P.A., March J.E., Bennett T. Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats. Br. J. Pharmacol. 1994, 111:589-597.
57. Ghatei M.A., Takahashi K., Suzuki H., Gardiner J.V., Jones P.M., Bloom S.R. Distribution, synthesis and molecular characterization of pituitary adenylate-cyclase activating polypeptide (PACAP) in rat-brain. Biomed. Res. 1992, 13:337-342.
58. Ghatei M.A., Takahashi K., Suzuki Y., Gardiner J., Jones P.M., Bloom S.R. Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger-RNA in human and rat-tissues. J. Endocrinol. 1993, 136:159-166.
59. Ghzili H., Grumolato L., Thouennon E., Tanguy Y., Turquier V., Vaudry H., Anouar Y. Role of PACAP in the physiology and pathology of the sympathoadrenal system. Front. Neuroendocrin. 2008, 29:128-141.
60. Gottschall P.E., Tatsuno I., Arimura A. Hypothalamic binding sites for pituitary adenylate cyclase activating polypeptide: characterization and molecular identification. FASEB J. 1991, 5:194-199.
61. Gottschall P.E., Tatsuno I., Miyata A., Arimura A. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide. Endocrinology 1990, 127:272-277.
62. Gourlet P., Vandermeers A., Robberecht P., Deschodt-lanckman M. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide (PACAP-27, but not PACAP-38) degradation by the neutral endopeptidase EC 3.4.24.11. Biochem. Pharmacol. 1997, 54:509-515.
63. Gourlet P., Vandermeers A., Vandermeers-Piret M.C., De Neef P., Robberecht P. Addition of the (28-38) peptide sequence of PACAP to the VIP sequence modifies peptide selectivity and efficacy. Int. J. Pept. Prot. Res. 1996, 48:391-396.
64. Gourlet P., De Neef P., Cnudde J., Waelbroeck M., Robberecht P. In vitro properties of a high affinity selective antagonist of the VIP1 receptor. Peptides 1997, 18:1555-1560.
65. Gray S.L., Cummings K.J., Jirik F.R., Sherwood N.M. Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism. Mol. Endocrinol. 2001, 15:1739-1747.
66. Gray S.L., Yamaguchi N., Vencova P., Sherwood N.M. Temperature-sensitive phenotype in mice lacking pituitary adenylate cyclase-activating polypeptide. Endocrinology 2002, 143:3946-3954.
67. Green B.D., Irwin N., Cassidy R.S., Gault V.A., Flatt P.R. Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice. Peptides 2006, 27:2343-2349.
68. Hamelink C., Tjurmina O., Damadzic R., Young W.S., Weihe E., Lee H.-W., Eiden L.E. Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis. Ann. N. Y. Acad. Sci. 2002, 99:461-466.
69. Hannibal J. Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study. J. Comp. Neurol. 2002, 453:389-417.
70. Hannibal J., Jamen F., Nielsen H.S., Journot L., Brabet P., Fahrenkrug J. Dissociation between light-induced phase shift of the circadian rhythm and clock gene expression in mice lacking the pituitary adenylate cyclase activating polypeptide type 1 receptor. J. Neurosci. 2001, 21:4883-4890.
71. Hannibal J., Mikkelsen J.D., Clausen H., Holst J.J., Wulff B.S., Fahrenkrug J. Gene expression of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat hypothalamus. Regul. Peptides 1995, 55:133.
72. Harmar A.J., Marston H.M., Shen S., Spratt C., West K.M., Sheward W.J., Morrison C.F., Dorin J.R., Piggins H.D., Reubi J.C., Kelly J.S., Maywood E.S., Hastings M.H. The VPAC(2) receptor is essential for circadian function in the mouse suprachiasmatic nuclei. Cell 2002, 109:497-508.
73. Harmar A.J. Family-B G-protein-coupled receptors. Genome Biol. 2001, 2:3013.1-3013.10.
74. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., Rawlings S.R., Robberecht P., Said S.I., Sreedharan S.P., Wank S.A., Waschek J.A. International Union of Pharmacology, XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 1998, 50:265-270.
75. Harrington M.E., Hoque S., Hall A., Golombek D., Biello S. Pituitary adenylate cyclase activating peptide phase shifts circadian rhythms in a manner similar to light. J. Neurosci. 1999, 19:6637-6642.
76. Hashimoto H., Shintani N., Baba A. New insights into the central PACAPergic system from the phenotypes in PACAP- and PACAP receptor-knockout mice. Ann. N. Y. Acad. Sci. 2006, 1070:75-89.
77. Hashimoto H., Ishihara T., Shigemoto R., Mori K., Nagata S. Molecular cloning and tissue distribution of a receptor for pituitary adenylate cyclase-activating polypeptide. Neuron 1993, 11:333-342.
78. Hashimoto H., Hagihara N., Koga K., Yamamoto K., Shintani N., Tomimoto S., Mori W., Koyama Y., Matsuda T., Baba A. Synergistic induction of pituitary adenylate cyclase-activating polypeptide (PACAP) gene expression by nerve growth factor and PACAP in PC12 cells. J. Neurochem. 2000, 74:501-507.
79. Hautmann M., Friis U.G., Desch M., Todorov V., Castrop H., Segerer F., Otto C., Schutz G., Schweda F. Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors. J. Am. Soc. Nephrol. 2007, 18:1150-1156.
80. Hong M., Yon L., Fournier A., Vaudry H., Pelletier G. Effect of pituitary adenylate cyclase-activating polypeptide (PACAP) on tyrosine hydroxylase gene expression in the rat adrenal medulla. Ann. N. Y. Acad. Sci. 1998, 865:478-481.
81. Hosoya M., Kimura C., Ogi K., Ohkubo S., Miyamoto Y., Kugoh H., Shimizu M., Onda H., Oshimura M., Arimura A., et al. Structure of the human pituitary adenylate cyclase activating polypeptide (PACAP) gene. Biochim. Biophys. Acta 1992, 1129:199-206.
82. Huang M., Shirahase H., Rorstad O.P. Comparative study of vascular relaxation and receptor binding by PACAP and VIP. Peptides 1992, 14:755-762.
83. Ishihara T., Shigemoto R., Mori K., Takahashi K., Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 1992, 8:811-819.
84. Jakab B., Reglodi D., Jozsa R., Hollosy T., Tamas A., Lubics A., Lengvari I., Oroszi G., Szilvassy Z., Szolcsanyi J., Nemeth J. Distribution of PACAP-38 in the central nervous system of various species determined by a novel radioimmunoassay. J. Biochem. Biophys. Meth. 2004, 61:189-198.
85. Jamen F., Persson K., Bertrand G., Rodriguez-Henche N., Puech R., Bockaert J., Ahren B., Brabet P. PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance. J. Clin. Invest. 2000, 105:1307-1315.
86. Jansen-Olesen I., Goadsby P., Uddman R., Edvinsson L. Vasoactive intestinal peptide (VIP) like peptides in the cerebral circulation of the cat. J. Autonom. Nerv. Syst. 1993, 49:S97-103.
87. Jolivel V., Basille M., Aubert N., de Jouffrey S., Ancian P., Le Bigot J.F., Noack P., Massonneau M., Fournier A., Vaudry H., Gonzalez B.J., Vaudry D. Distribution and functional characterization of pituitary adenylate cyclase-activating polypeptide receptors in the brain of non-human primates. Neuroscience 2009, 160:434-451.
88. Jongsma H., Danielsen N., Sundler F., Kanje M. Alteration of PACAP distribution and PACAP receptor binding in the rat sensory nervous system following sciatic nerve transection. Brain Res. 2000, 853:186-196.
89. Jongsma H., Pettersson L.M., Zhang Y., Reimer M.K., Kanje M., Waldenstrom A., Sundler F., Danielsen N. Markedly reduced chronic nociceptive response in mice lacking the PAC1 receptor. Neuroreport 2001, 12:2215-2219.
90. Kalamatianos T., Kalló I., Piggins H.D., Coen C.W. Expression of VIP and/or PACAP receptor mRNA in peptide synthesizing cells within the suprachiasmatic nucleus of the rat and in its efferent target sites. J. Comp. Neurol. 2004, 475:19-35.
91. Kallo I., Kalamatianos T., Wiltshire N., Shen S.B., Sheward W.J., Harmar A.J., Coen C.W. Transgenic approach reveals expression of the VPAC(2) receptor in phenotypically defined neurons in the mouse suprachiasmatic nucleus and in its efferent target sites. Eur. J. Neurosci. 2004, 19:2201-2211.
92. Kawaguchi C., Tanaka K., Isojima Y., Shintani N., Hashimoto H., Baba A., Nagai K. Changes in light-induced phase shift of circadian rhythm in mice lacking PACAP. Biochem. Biophys. Res. Commun. 2003, 310:169-175.
93. Koves K., Gorcs T.J., Kausz M., Arimura A. Present status of knowledge about the distribution and colocalization of PACAP in the forebrain. Acta Biol. Hung. 1994, 45:297-321.
94. Koves K., Arimura A., Somogyvari-Vigh A., Vigh S., Miller J. Immunohistochemical demonstration of a novel hypothalamic peptide, pituitary adenylate cyclase-activating polypeptide, in the ovine hypothalamus. Endocrinology 1990, 127:264-271.
95. Krowicki Z.K., Arimura A., Nathan N.A., Hornby P.J. Hindbrain effects of PACAP on gastric motor function in the rat. Am. J. Physiol. 1997, 35:G1221-G1229.
96. Kyeung M.J., Yoon H.C., Min K.K., Ryoung H.N., Byung L.L., Kyung H.L., Choong I.C. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. J. Comp. Neurol. 2004, 476:388-413.
97. Laburthe M., Couvineau A. Molecular pharmacology and structure of VPAC Receptors for VIP and PACAP. Regul. Peptides 2002, 108:165-173.
98. Lai C.C., Wu S.Y., Lin H.H., Dun N.J. Excitatory action of pituitary adenylate cyclase activating polypeptide on rat sympathetic preganglionic neurons in vivo and in vitro. Brain Res. 1997, 748:189.
99. Lam H.C., Takahashi K., Ghatei M.A., Kanse S.M., Polak J.M., Bloom S.R. Binding sites of a novel neuropeptide pituitary-adenylate-cyclase-activating polypeptide in the rat brain and lung. Eur. J. Biochem. 1990, 193:725-729.
100. Legradi G., Shioda S., Arimura A. Pituitary adenylate cyclase-activating polypeptide-like immunoreactivity in autonomic regulatory areas of the rat medulla oblongata. Neurosci. Lett. 1994, 176:193.
101. Li M., Mbikay M., Arimura A. Pituitary adenylate cyclase activating polypeptide precursor is processed solely by prohormone convertase 4 in the gonads. Endocrinology 2000, 141:3723-3730.
102. 1 cells. Neuroendocrinology 1999, 69:217-226.
103. Li M., Nakayama K., Shuto Y., Somogyvari-Vigh A., Arimura A. Testis-specific prohormone convertase PC4 processes the precursor of pituitary adenylate cyclase-activating polypeptide (PACAP). Peptides 1998, 19:259-268.
104. Li M., Mbikay M., Nakayama K., Miyata A., Arimura A. Prohormone convertase PC4 processes the precursor of PACAP in the testis. Ann. N. Y. Acad. Sci. 2000, 921:333-339.
105. Linden A., Cardell L.O., Yoshihara S., Nadel J.A. Bronchodilation by pituitary adenylate cyclase-activating peptide and related peptides. Eur. Respir. J. 1999, 14:443-451.
106. Lutz E.M., Sheward W.J., West K.M., Morrow J.A., Fink G., Harmar A.J. The VIP2 receptor: molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 1993, 334:3-8.
107. Madden C.J., Stocker S.D., Sved A.F. Attenuation of homeostatic responses to hypotension and glucoprivation after destruction of catecholaminergic rostral ventrolateral medulla neurons. Am. J. Physiol. 2006, 291:R751-759.
108. Maekawa F., Fujiwara K., Tsukahara S., Yada T. Pituitary adenylate cyclase-activating polypeptide neurons of the ventromedial hypothalamus project to the midbrain central gray. Neuroreport 2006, 17:221-224.
109. Markos F., Hennessy B.A., Fitzpatrick M., O'Sullivan J., Snow H.M. An evaluation of the efficacy of vasoactive intestinal polypeptide antagonists in vivo in the anaesthetized dog. Pharmacology 2002, 66:206-210.
110. Masuo Y., Ohtaki T., Masuda Y., Nagai Y., Suno M., Tsuda M., Fujino M. Autoradiographic distribution of pituitary adenylate cyclase activating polypeptide (PACAP) binding sites in the rat brain. Neurosci. Lett. 1991, 126:103-106.
111. Masuo Y., Suzuki N., Matsumoto H., Tokito F., Matsumoto Y., Tsuda M., Fujino M. Regional distribution of pituitary adenylate cyclase activating polypeptide (PACAP) in the rat central nervous system as determined by sandwich-enzyme immunoassay. Brain Res. 1993, 602:57-63.
112. Matsuda K., Maruyama K., Miura T., Uchiyama M., Shioda S. Anorexigenic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: Feeding-induced changes in the expression of mRNAs for PACAP and its receptors in the brain, and locomotor response to central injection. Neurosci. Lett. 2005, 386:9-13.
113. Matsuyama S., Matsumoto A., Hashimoto H., Shintani N., Baba A. Impaired long-term potentiation in vivo in the dentate gyrus of pituitary adenylate cyclase-activating polypeptide (PACAP) or PACAP type 1 receptor-mutant mice. Neuroreport 2003, 14:2095-2098.
114. McCulloch D.A., Lutz E.M., Johnson M.S., MacKenzie C.J., Mitchell R. Differential activation of phospholipase D by VPAC and PAC1 receptors. Ann. N. Y. Acad. Sci. 2000, 921:175-185.
115. Minkes R.K., McMahon T.J., Higuera T.R., Murphy W.A., Coy D.H., Kadowitz P.J. Analysis of systemic and pulmonary vascular responses to PACAP and VIP: role of adrenal catecholamines. Am. J. Physiol. 1992, 263:H1659-1669.
116. Miyata A., Sato K., Hino J., Tamakawa H., Matsuo H., Kangawa K. Rat aortic smooth-muscle cell proliferation is bidirectionally regulated in a cell cycle-dependent manner via PACAP/VIP type 2 receptor. Ann. N. Y. Acad. Sci. 1998, 865:73-81.
117. Miyata A., Arimura A., Dahl R., Minamino N., Uehara A., Jiang L., Culler M., Coy D. Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 1989, 164(1):567-574. (1989 (October), 567-574).
118. Miyata A., Jiang L., Dahl R.D., Kitada C., Kubo K., Fujino M., Minamino N., Arimura A. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem. Biophys. Res. Commmun. 1990, 170:643-648.
119. Moller K., Sundler F. Expression of pituitary adenylate cyclase activating peptide (PACAP) and PACAP type I receptors in the rat adrenal medulla. Regul. Pept. 1996, 63:129-139.
120. Morrison S.F., Cao W.H. Different adrenal sympathetic preganglionic neurons regulate epinephrine and norepinephrine secretion. Am. J. Physiol. 2000, 279:R1763-1775.
121. Morrison S.F., Sved A.F., Passerin A.M. GABA-mediated inhibition of raphe pallidus neurons regulates sympathetic outflow to brown adipose tissue. Am. J. Physiol. 1999, 276:R290-297.
122. Morrison S.F., Cao W.H., Madden C.J. Dorsomedial hypothalamic and brainstem pathways controlling thermogenesis in brown adipose tissue. J. Therm. Biol. 2004, 29:333-337.
123. Moser A., Scholz J., Gansle A. Pituitary adenylate cyclase-activating polypeptide (PACAP-27) enhances tyrosine hydroxylase activity in the nucleus accumbens of the rat. Neuropeptides 1999, 33:492-497.
124. Mounien L., Bizet P., Boutelet I., Gourcerol G., Basille M., Gonzalez B., Vaudry H., Jegou S. Expression of PACAP receptor mRNAs by neuropeptide Y neurons in the rat arcuate nucleus. Ann. N. Y. Acad. Sci. 2006, 1070:457-461.
125. Mounien L., Bizet P., Boutelet I., Gourcerol G., Fournier A., Vaudry H., Jegou S. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus. Neuroscience 2006, 143:155-163.
126. Muller A., Monnier D., Rene F., Larmet Y., Koch B., Loeffler J. Pituitary adenylate cyclase-activating polypeptide triggers dual transduction signaling in CATH.a cells and transcriptionally activates tyrosine hydroxylase and c-fos expression. J. Neurochem. 1997, 68:1696-1704.
127. Murase T., Kondo K., Otake K., Oiso Y. Pituitary adenylate cyclase-activating polypeptide stimulates arginine vasopressin release in conscious rats. Neuroendocrinology 1993, 57:1092-1096.
128. Murase T., Kondo K., Arima H., Iwasaki Y., Ito M., Miura Y., Oiso Y. The expression of pituitary adenylate cyclase-activating polypeptide (PACAP) mRNA in rat brain: possible role of endogenous PACAP in vasopressin release. Neurosci. Lett. 1995, 185:103-106.
129. Nakata M., Yada T. PACAP in the glucose and energy homeostasis: physiological role and therapeutic potential. Curr. Pharm. Des. 2007, 13:1105-1112.
130. Nakata M., Kohno D., Shintani N., Nemoto Y., Hashimoto H., Baba A., Yada T. PACAP deficient mice display reduced carbohydrate intake and PACAP activates NPY-containing neurons in the rat hypothalamic arcuate nucleus. Neurosci. Lett. 2004, 370:252-256.
131. Nicot A., Otto T., Brabet P., DiCicco-Bloom E.M. Altered social behavior in pituitary adenylate cyclase-activating polypeptide type I receptor-deficient mice. J. Neurosci. 2004, 24:8786-8795.
132. Nogi H., Hashimoto H., Fujita T., Hagihara N., Matsuda T., Baba A. Pituitary adenylate cyclase-activating polypeptide (PACAP) receptor mRNA in the rat adrenal gland: localization by in situ hybridization and identification of splice variants. Jpn. J. Pharmacol. 1997, 75:203-207.
133. Nonaka N., Shioda S., Banks W.A. Effect of lipopolysaccharide on the transport of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier. Exp. Neurol. 2005, 191:137-144.
134. Ogawa T., Nakamachi T., Ohtaki H., Hashimoto H., Baba N.S., Watanabe A., Kikuyama J., Shioda S. Monoaminergic neuronal development is not affected in PACAP-gene-deficient mice. Regul. Peptides 2005, 126:103.
135. Ohsawa M., Brailoiu G.C., Shiraki M., Dun N.J., Paul K., Tseng L.F. Modulation of nociceptive transmission by pituitary adenylate cyclase activating polypeptide in the spinal cord of the mouse. Pain 2002, 100:27-34.
136. Ohtaki H., Nakamachi T., Dohi K., Shioda S. Role of PACAP in ischemic neural death. J. Mol. Neurosci. 2008, 36:16-25.
137. Okazaki K., Kimura C., Kosaka T., Watanabe T., Ohkubo S., Ogi K., Kitada C., Onda H., Fujino M. Expression of human pituitary adenylate cyclase activating polypeptide (PACAP) cDNA in CHO cells and characterization of the products. FEBS Lett. 1992, 298:49-56.
138. Otto C., Martin M., Paul Wolfer D., Lipp H.-P., Maldonado R., Schütz G. Altered emotional behavior in PACAP-type-I-receptor-deficient mice. Mol. Brain Res. 2001, 92:78-84.
139. Otto C., Kovalchuk Y., Wolfer D.P., Gass P., Martin M., Zuschratter W., Grone H.J., Kellendonk C., Tronche F., Maldonado R., Lipp H.-P., Konnerth A., Schutz G. Impairment of mossy fiber long-term potentiation and associative learning in pituitary adenylate cyclase activating polypeptide type I receptor-deficient mice. J. Neurosci. 2001, 21:5520-5527.
140. Pakhotin P., Harmar A.J., Verkhratsky A., Piggins H. VIP receptors control excitability of suprachiasmatic nuclei neurones. Pflug. Arch. Eur. J. Physiol. 2006, 452:7-15.
141. Pẽna F. PACAP modulates the respiratory rhythm generated in the brainstem slice preparation. Adv. Exp. Med. Biol. 2010, 669:119-122.
142. Pettersson L.M., Heine T., Verge V., Sundler F., Danielsen N. PACAP mRNA is expressed in rat spinal cord neurons. J. Comp. Neurol. 2004, 471:85-96.
143. Robberecht P., Gourlet P., De Neef P., Woussen-Colle M.C., Vandermeers-Piret M.C., Vandermeers A., Christophe J. Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist. Eur. J. Biochem. 1992, 207:239-246.
144. Ross-Ascuitto N.T., Ascuitto R.J., Ramage D., Kydon D.W., Coy D.H., Kadowitz P.J. Pituitary adenylate cyclase activating polypeptide: a neuropeptide with potent inotropic and coronary vasodilatory effects in neonatal pig hearts. Pediatr. Res. 1993, 34:323-328.
145. Runcie M.J., Ulman L.G., Potter E.K. Effects of pituitary adenylate cyclase-activating polypeptide on cardiovascular and respiratory responses in anaesthetised dogs. Regul. Peptides 1995, 60:193-200.
146. Seidah N.G., Day R., Marcinkiewicz M., Chretien M. Precursor convertases: an evolutionary ancient, cell-specific, combinatorial mechanism yielding diverse bioactive peptides and proteins. Ann. N. Y. Acad. Sci. 1998, 839:9-24.
147. Seki T., Shioda S., Nakai Y., Arimura A., Koide R. Distribution and ultrastructural localization of pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptor in the rat retina. Ann. N. Y. Acad. Sci. 1998, 865:408-411.
148. Seki T., Shioda S., Ogino D., Nakai Y., Arimura A., Koide R. Distribution and ultrastructural localization of a receptor for pituitary adenylate cyclase activating polypeptide and its mRNA in the rat retina. Neurosci. Lett. 1997, 238:127-130.
149. Seki Y., Suzuki Y., Baskaya M.K., Saito K., Takayasu M., Shibuya M., Sugita K. Central cardiovascular effects induced by intracisternal PACAP in dogs. Am. J. Physiol. 1995, 269:H135-139.
150. Sherwood N.M., Krueckl S.L., McRory J.E. The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. Endocr. Rev. 2000, 21:619-670.
151. Shioda S., Ohtaki H., Nakamachi T., Dohi K., Watanabe J., Nakajo S., Arata S., Kitamura S., Okuda H., Takenoya F., Kitamura Y. Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment. Ann. N. Y. Acad. Sci. 2006, 1070:550-560.
152. Shioda S., Shuto Y., Somogyvari-Vigh A., Legradi G., Onda H., Coy D.H., Nakajo S., Arimura A. Localization and gene expression of the receptor for pituitary adenylate cyclase-activating polypeptide in the rat brain. Neurosci. Res. 1997, 28:345-354.
153. Shivers B.D., Gorcs T.J., Gottschall P.E., Arimura A. Two high affinity binding sites for pituitary adenylate cyclase-activating polypeptide have different tissue distributions. Endocrinology 1991, 128:3055-3065.
154. Somogyvari-Vigh A., Pan W., Reglodi D., Kastin A.J., Arimura A. Effect of middle cerebral artery occlusion on the passage of pituitary adenylate cyclase activating polypeptide across the blood-brain barrier in the rat. Regul. Peptides 2000, 91:89-95.
155. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P.H., Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature 1993, 365:170-175.
156. Sundler F., Ekblad E., Hannibal J., Moller K., Zhang Y.Z., Mulder H., Elsas T., Grunditz T., Danielsen N., Fahrenkrug J., Uddman R. Pituitary adenylate cyclase-activating peptide in sensory and autonomic ganglia: localization and regulation. Ann. N. Y. Acad. Sci. 1996, 805:410-428.
157. Suzuki Y., Kasai K., Takekoshi K., Oka M., Banba N., Numao T., Sugimura H., Iizuka M., Shimoda S.-I. Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the cardiovascular system. Regul. Peptides 1993, 47:213.
158. Tanida M., Shintani N., Morita Y., Tsukiyama N., Hatanaka M., Hashimoto H., Sawai H., Baba A., Nagai K. Regulation of autonomic nerve activities by central pituitary adenylate cyclase-activating polypeptide. Regul. Peptides 2010, 10.1016/j.regpep.2010.02.002.
159. Tonshoff C., Hemmick L., Evinger M.J. Pituitary adenylate cyclase activating polypeptide (PACAP) regulates expression of catecholamine biosynthetic enzyme genes in bovine adrenal chromaffin cells. J. Mol. Neurosci. 1997, 9:127-140.
160. Uddman R., Goadsby P., Jansen I., Edvinsson L. PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow. J. Cerebr. Blood F. Met. 1993, 13:291-297.
161. Vaudry D., Gonzalez B.J., Basille M., Yon L., Fournier A., Vaudry H. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 2000, 52:269-324.
162. Watanabe T., Masuo Y., Matsumoto H., Suzuki N., Ohtaki T., Masuda Y., Kitada C., Tsuda M., Fujino M. Pituitary adenylate cyclase activating polypeptide provokes cultured rat chromaffin cells to secrete adrenaline. Biochem. Biophys. Res. Commun. 1992, 182:403-411.
163. White S.L., May V., Braas K.M. Organization of the rat PACAP gene. Ann. N. Y. Acad. Sci. 2000, 921:370-372.
164. Wilson R.J.A., Cummings K.J. Pituitary adenylate cyclase-activating polypeptide is vital for neonatal survival and the neuronal control of breathing. Resp. Physiol. Neurobiol. 2008, 164:168-178.
165. Wong A.O.L., Leung M.Y., Shea W.L.C., Tse L.Y., Chang J.P., Chow B.K.C. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor. Endocrinology 1998, 139:3465-3479.
166. Wong D.L., Anderson L.J., Tai T.C. Cholinergic and peptidergic regulation of phenylethanolamine N-methyltransferase gene expression. Ann. N. Y. Acad. Sci. 2002, 971:19-26.
167. Yokota C., Kawai K., Ohashi S., Watanabe Y., Yamashita K. PACAP stimulates glucose output from the perfused rat liver. Peptides 1995, 16:55-60.
168. Zheng M., Streck R., Scott R., Seidah N., Pintar J. The developmental expression in rat of proteases furin, PC1, PC2, and carboxypeptidase E: implications for early maturation of proteolytic processing capacity. J. Neurosci. 1994, 14:4656-4673.
169. Zhou C.J., Kikuyama S., Shibanuma M., Hirabayashi T., Nakajo S., Arimura A., Shioda S. Cellular distribution of the splice variants of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC(1)-R) in the rat brain by in situ RT-PCR. Mol. Brain Res. 2000, 75:150-158.
170. Zhu L., Tamvakopoulos C., Xie D., Dragovic J., Shen X., Fenyk-Melody J.E., Schmidt K., Bagchi A., Griffin P.R., Thornberry N.A., Sinha Roy R. The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide(1-38). J. Biol. Chem. 2003, 278:22418-22423.
171. Zigmond R.E., Schwarzschild M.A., Rittenhouse A.R. Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation. Annu. Rev. Neurosci. 1989, 12:415-461.